✦ LIBER ✦

Efficacy and safety of rivaroxaban compared with warfarin in patients with peripheral artery disease and non-valvular atrial fibrillation: insights from ROCKET AF

✍ Scribed by Jones, W. S.; Hellkamp, A. S.; Halperin, J.; Piccini, J. P.; Breithardt, G.; Singer, D. E.; Fox, K. A. A.; Hankey, G. J.; Mahaffey, K. W.; Califf, R. M.; Patel, M. R.

Book ID: 121475377
Publisher: Oxford University Press
Year: 2013
Tongue: English
Weight: 290 KB
Volume: 35
Category: Article
ISSN: 0195-668X
DOI: 10.1093/eurheartj/eht492

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

OUTCOMES OF PATIENTS WITH ATRIAL FIBRILL

OUTCOMES OF PATIENTS WITH ATRIAL FIBRILLATION AND SIGNIFICANT VALVULAR LESIONS: COMPARISON OF THE EFFECTS OF RIVAROXABAN AND WARFARIN IN THE ROCKET AF TRIAL

✍ Breithardt, Guenter; Berkowitz, Scott; Baumgartner, Helmut; Hellkamp, Anne; Picc 📂 Article 📅 2013 🏛 Elsevier Science 🌐 English ⚖ 151 KB

Rivaroxaban versus warfarin in Japanese

Rivaroxaban versus warfarin in Japanese patients with non-valvular atrial fibrillation in relation to hypertension: a subgroup analysis of the J-ROCKET AF trial

✍ Matsumoto, Masayasu; Hori, Masatsugu; Tanahashi, Norio; Momomura, Shin-ichi; Uch 📂 Article 📅 2014 🏛 Nature Publishing Group 🌐 English ⚖ 302 KB

Rivaroxaban compared with warfarin in pa

Rivaroxaban compared with warfarin in patients with atrial fibrillation and previous stroke or transient ischaemic attack: a subgroup analysis of ROCKET AF

✍ Graeme J Hankey; Manesh R Patel; Susanna R Stevens; Richard C Becker; Günter Bre 📂 Article 📅 2012 🏛 The Lancet 🌐 English ⚖ 252 KB

Meta-Analysis of Efficacy and Safety of

Meta-Analysis of Efficacy and Safety of Rivaroxaban Compared With Warfarin or Dabigatran in Patients Undergoing Catheter Ablation for Atrial Fibrillation

✍ Aryal, Madan Raj; Ukaigwe, Anene; Pandit, Anil; Karmacharya, Paras; Pradhan, Raj 📂 Article 📅 2014 🏛 Elsevier Science 🌐 English ⚖ 283 KB

Meta-Analysis of Efficacy and Safety of

Meta-Analysis of Efficacy and Safety of New Oral Anticoagulants (Dabigatran, Rivaroxaban, Apixaban) Versus Warfarin in Patients With Atrial Fibrillation

✍ Corey S. Miller; Sonia M. Grandi; Avi Shimony; Kristian B. Filion; Mark J. Eisen 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 926 KB

C0131 Comparison of the efficacy and saf

C0131 Comparison of the efficacy and safety of dabigatran, rivaroxaban and apixaban in patients with non-valvular atrial fibrillation using network meta-analysis

✍ Marx, Svetlana; Harenberg, Job; Wehling, Martin; Weiss, Christel; Diener, Hans-C 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 131 KB